Are Cell and Gene Therapy Innovations Ready for Widespread Use?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

Treatment of diseases like cancer and HIV is hitting a new frontier with cell-based therapy. This new therapy invigorates the medical world, but it’s not widely accessible yet. Discussing the breakthroughs in these treatments, I Don’t Care host Kevin Stevenson spoke with immunologist Dr. Chris Xu, CEO of ThermoGenesis, a medical device company that’s a pioneer in the field.

“Cell-based therapy came about 13 years ago, and we’ve been fostering the field around cord blood, with 90% of FDA approved cord blood stored in a nitrogen system we developed,” Dr. Xu explained.

That was the company’s beginning, but it has aspirations to do much more. That requires a shift in treatment perspective. “We’ve long used drugs to treat illnesses, but cancer is much more complex. The newly approved therapy takes a patient’s T-cells, which are part of the immune system. It reprograms them to recognize cancer and fight it. It’s the future of medicine,” Dr. Xu said.

“Using someone’s T-cells turns their body into the best defense mechanism against disease.” – Dr. Chris Xu

Thus far, Dr. Xu reported that patients with leukemia and lymphomas have a 93% response rate. He also noted that cancer treatment is just the beginning. Over 1200 trials targeting every type of cancer are ongoing.

HIV is another disease where cell gene therapy has promise. “We discovered that a small percentage of the population doesn’t carry the receptor for HIV, which is necessary for the virus to enter a cell. We can modify cells not to have it, making the patient HIV resistant.”

While the promise of new treatments is here, Dr. Xu noted there are two big impediments. One is cost, with treatments costing as much as $500,000. The other is that patients may no longer have T-cells due to radiation, chemo, or other issues. That’s why he recommends storing cord blood for future use.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in HVAC
AI in HVAC Speeds Up Troubleshooting, Automates Training, and Connects Techs to the Right Data Instantly
September 16, 2025

Artificial intelligence is rapidly transforming field service operations across skilled trades, and HVAC is no exception. AI in HVAC is reshaping how technicians access information, troubleshoot systems, and stay productive on the job. As the industry faces an ongoing labor shortage and rising equipment complexity, the need for smarter tools is urgent, especially as…

Read More
meaningful connection
Beyond “How Are You?”: Creating Meaningful Connection That Fuels Professional Growth
September 16, 2025

What happens when we stop asking surface-level questions and start having conversations that actually matter? Everyday greetings like “How are you?” often miss the chance to spark a genuine and meaningful connection. Research suggests that authentic connection boosts employee engagement and retention, with studies showing that employees who feel recognized and genuinely valued are…

Read More
Education
Shaping the World of Education: The Broadband Industry’s Impact on Academia, Part 1
September 16, 2025

In this episode of Wavelengths, the Amphenol Broadband Solutions podcast, host Daniel Litwin sits down with Chuck Girt, Chief Technology Officer at FiberLight, to explore how broadband innovation is shaping the future of education. As schools embrace 1:1 devices, cloud-based curriculum, and even emerging AI-driven learning tools, their networks are under more pressure than ever….

Read More
AP poll
College Football’s AP Poll: Should Voter Rights Be Revoked?
September 12, 2025

The early weeks of college football are once again putting the AP poll under a microscope, with a controversial ballot sparking debate over voter accountability and the disconnect between initial rankings and on-field performance. At the same time, financial pressures are reshaping both college and pro football, from coaching buyouts to roster strain created by…

Read More